Insider Trading disclosures for Jatt II Acquisition Corp
The latest disclosure was made by Dr. Someit Sidhu, M.D. in Jatt II Acquisition Corp where a trade of 225,000
Ordinary Shares done
was reported to US exchanges on June 6, 2026.
Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Client Name |
Client Category |
Action |
Reported to Exchange |
Quantity |
Post Transaction Holding |
Traded % |
Avg. Price |
Value |
Security Type |
|
Dr. Someit Sidhu, M.D.
|
Director, Chief Executive Officer, Ten Percent Owner |
Other type of transaction at price $ 0.00 per share. |
06 Jun 2026 |
225,000 |
1,800,000
|
-
|
|
0
|
Ordinary Shares |
|
Dr. Someit Sidhu, M.D.
|
Director, Chief Executive Officer, Ten Percent Owner |
Purchase of securities on an exchange or from another person at price $ 0.00 per share. |
20 Apr 2026 |
300,000 |
2,025,000
|
-
|
|
-
|
Ordinary shares |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges